US 10869851
Targeting NUR77 for mitigating perinatal neuroinflammation
granted A61KA61K31/216A61K31/57
Quick answer
US patent 10869851 (Targeting NUR77 for mitigating perinatal neuroinflammation) held by United States Government as represented by the Secretary of the Army expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United States Government as represented by the Secretary of the Army
- Grant date
- Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/216, A61K31/57, A61K31/573, A61K45/06